NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.
With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.
Guest author, Dr Rosanna Jackson, outlines what scientists are doing to make treatment for one type of childhood leukaemia kinder.
Our scientists are working to improve brain tumour diagnosis. Find out how this could make treatment more personal, and guide people onto clinical trials.
New research has shown that an intelligent knife can distinguish between ovarian cancer and normal tissue. Could it help make ovarian cancer surgery smarter?
Will personalised medicine become the norm of cancer treatment? In this Science Surgery instalment, we asked experts for their thoughts on this question.
Physicists in Cambridge are using light and sound to gather information on prostate cancer in mice. This could show doctors how aggressive a tumour is.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.